Correspondingly, previous reports have shown that the presence of survivin is associated with poor survival among patients with colorectal cancer (Kawasaki et al, 1998), non small-cell lung cancer (Monzo et al, 1999), breast cancer (Tanaka et al, 2000) and neuroblastoma (Adida et al, 1998). The gene discussed is BIRC5; the disease is neuroblastoma.